1. Home
  2. GSIW vs PPBT Comparison

GSIW vs PPBT Comparison

Compare GSIW & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIW
  • PPBT
  • Stock Information
  • Founded
  • GSIW 2016
  • PPBT 2010
  • Country
  • GSIW Hong Kong
  • PPBT Israel
  • Employees
  • GSIW N/A
  • PPBT N/A
  • Industry
  • GSIW
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSIW
  • PPBT Health Care
  • Exchange
  • GSIW Nasdaq
  • PPBT Nasdaq
  • Market Cap
  • GSIW 12.3M
  • PPBT 8.7M
  • IPO Year
  • GSIW 2023
  • PPBT N/A
  • Fundamental
  • Price
  • GSIW $0.79
  • PPBT $3.00
  • Analyst Decision
  • GSIW
  • PPBT Strong Buy
  • Analyst Count
  • GSIW 0
  • PPBT 2
  • Target Price
  • GSIW N/A
  • PPBT $126.50
  • AVG Volume (30 Days)
  • GSIW 11.3M
  • PPBT 38.0K
  • Earning Date
  • GSIW 12-31-2024
  • PPBT 03-04-2025
  • Dividend Yield
  • GSIW N/A
  • PPBT N/A
  • EPS Growth
  • GSIW N/A
  • PPBT N/A
  • EPS
  • GSIW N/A
  • PPBT N/A
  • Revenue
  • GSIW $1,313,795.00
  • PPBT N/A
  • Revenue This Year
  • GSIW N/A
  • PPBT N/A
  • Revenue Next Year
  • GSIW N/A
  • PPBT N/A
  • P/E Ratio
  • GSIW N/A
  • PPBT N/A
  • Revenue Growth
  • GSIW N/A
  • PPBT N/A
  • 52 Week Low
  • GSIW $0.43
  • PPBT $2.00
  • 52 Week High
  • GSIW $15.45
  • PPBT $20.60
  • Technical
  • Relative Strength Index (RSI)
  • GSIW 64.32
  • PPBT 40.77
  • Support Level
  • GSIW $0.44
  • PPBT $3.12
  • Resistance Level
  • GSIW $0.51
  • PPBT $3.37
  • Average True Range (ATR)
  • GSIW 0.11
  • PPBT 0.24
  • MACD
  • GSIW 0.01
  • PPBT -0.01
  • Stochastic Oscillator
  • GSIW 43.39
  • PPBT 21.93

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Share on Social Networks: